Three Questions About Hearing and the Mind, Three Designs: What a Cohort Study, a Randomized Trial and a Commission Review Can and Cannot Tell a Nurse Practitioner About Hearing Loss and Dementia
[Student Name]
University of Phoenix
NRP/513: Clinical Applications of Theory and Research
Week 4 Assignment
[Instructor Name]
[Date]
The clinical context is a composite written for a model paper.
A patient recently asked me whether wearing hearing aids would prevent dementia. To answer honestly, I need to understand not only what studies found but what their designs allow them to conclude. This paper examines three studies on hearing loss and cognition, each using a different design.
Design 1: A Prospective Cohort Study
Lin et al. (2011) followed 639 adults without dementia in the Baltimore Longitudinal Study of Aging, measuring hearing at baseline and tracking incident dementia over a median of 11.9 years. The risk of all-cause dementia increased with the severity of hearing loss, by a hazard ratio of 1.27 per 10 decibels of loss. Compared with normal hearing, the hazard ratio was 1.89 for mild, 3.00 for moderate and 4.94 for severe hearing loss.
What the design can show: a prospective cohort establishes that exposure preceded outcome and can show a dose-response relationship, both of which support a causal interpretation. It can adjust statistically for measured confounders.
What it cannot show: without random assignment, unmeasured differences between people with and without hearing loss might explain the association. The authors themselves noted that hearing loss might be a marker of early dementia rather than a cause. The confidence intervals for mild and severe loss were wide because the number of dementia cases was small.
Design 2: A Randomized Controlled Trial
The ACHIEVE trial randomly assigned 977 adults aged 70 to 84 with untreated hearing loss and without substantial cognitive impairment to a hearing intervention, including audiologist-fitted hearing aids and counseling, or to a health education control (Lin et al., 2023). In the primary analysis, three-year cognitive decline did not differ significantly between groups. A prespecified sensitivity analysis found that the effect differed between participants recruited from an existing cohort study, who were older and at higher risk of cognitive decline, and newly recruited participants, suggesting that the hearing intervention might slow decline in higher-risk older adults but not in lower-risk ones.
What the design can show: random assignment balances known and unknown confounders, so a difference in outcomes can be attributed to the intervention. It is the strongest design for testing whether treatment causes benefit.
What it cannot show: the primary result was negative, so the trial does not demonstrate that hearing aids prevent cognitive decline in general. Subgroup findings, even prespecified, are less certain than the primary result and need confirmation. Three years may be too short to detect effects on dementia itself, and most participants were White, limiting generalizability.
The observational study raised the question, and the trial, by answering it only partly, taught me how to talk about it honestly.
Design 3: An Expert Commission Synthesis
The Lancet Commission on dementia prevention, intervention and care synthesized evidence from many studies to estimate the share of dementia attributable to modifiable risk factors (Livingston et al., 2020). It identified 12 modifiable risk factors that together accounted for about 40% of dementias worldwide and estimated that hearing loss in midlife had the largest population attributable fraction of any single factor, about 8%.
What the design can show: a synthesis integrates evidence across studies and settings, providing a broad view that no single study can. Population attributable fractions translate risk into potential public health impact.
What it cannot show: population attributable fractions assume that the associations are causal and that removing the risk factor would remove the attributable dementia, assumptions that the ACHIEVE primary analysis did not confirm. Its conclusions inherit the weaknesses of the studies it combines, and many of those were observational.
Reading the Numbers Carefully
The hazard ratios in the cohort study invite overinterpretation. A hazard ratio of 4.94 for severe hearing loss sounds dramatic, but its confidence interval ran from 1.09 to 22.40, showing great uncertainty because few participants had severe loss and few developed dementia (Lin et al., 2011). The estimate of 1.27 per 10 decibels, with a narrower interval, is more reliable. Reading intervals, not only point estimates, is part of understanding what a design has shown.
The Level of Evidence Each Provides
Evidence hierarchies place randomized trials above cohort studies for questions about whether an intervention works, because of their protection against confounding. Hierarchies can mislead, however, when a single trial is weighed against many observational studies without considering what each asked. The cohort answered whether hearing loss predicts dementia; the trial answered whether a hearing intervention changes cognitive decline over three years. They are not competing answers to one question but answers to related questions, and both are needed.
Qualitative Designs: The Missing Question
None of these designs answers why older adults do or do not wear hearing aids or what hearing loss means to them. Qualitative designs, such as interviews and focus groups, would address those questions, which Weeks 2 and 3 identified as central to my clinical problem.
Mixed Methods
A mixed methods design could combine the strengths of both approaches for my clinical problem: a quantitative measure of hearing aid use and cognitive screening scores over a year, paired with interviews exploring why some patients kept wearing their devices and others stopped. The quantitative data would show what happened, and the interviews would explain why.
Putting It Together
The cohort study shows a strong, graded association between hearing loss and dementia. The commission estimates a large potential impact if the association is causal. The trial tested causation directly and found no overall effect over three years, with a possible benefit in higher-risk older adults.
Why This Matters for My Clinical Problem
My problem is hearing aid uptake and use, not dementia prevention. Yet the dementia question is often the reason patients and families give for seeking hearing aids, and some clinicians use it to motivate patients. The evidence reviewed here tells me to be careful: motivating patients with a benefit the main trial did not demonstrate risks disappointment and mistrust. The benefits for hearing, communication and daily life are better established and should lead the conversation.
What I Told My Patient
I told her that people with hearing loss have a higher risk of dementia, that a large trial did not show that hearing aids reduced cognitive decline over three years for everyone, but that there may be a benefit for some people at higher risk, and that hearing aids clearly help people hear and communicate, which matters for daily life, safety and relationships. That answer respects both the evidence and its limits.
Conclusion
Three designs gave three kinds of knowledge about hearing loss and cognition: association and dose-response from a cohort, a test of causation from a randomized trial and an estimate of population impact from a synthesis. Understanding what each design can and cannot show allows a nurse practitioner to speak accurately with patients, neither overstating hearing aids as dementia prevention nor dismissing their value.
References
Lin, F. R., Metter, E. J., O'Brien, R. J., Resnick, S. M., Zonderman, A. B., & Ferrucci, L. (2011). Hearing loss and incident dementia. Archives of Neurology, 68(2), 214-220. https://doi.org/10.1001/archneurol.2010.362
Lin, F. R., Pike, J. R., Albert, M. S., Arnold, M., Burgard, S., Chisolm, T., Couper, D., Deal, J. A., Goman, A. M., Glynn, N. W., Gmelin, T., Gravens-Mueller, L., Hayden, K. M., Huang, A. R., Knopman, D., Mitchell, C. M., Mosley, T., Pankow, J. S., Reed, N. S., . . . Coresh, J. (2023). Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): A multicentre, randomised controlled trial. The Lancet, 402(10404), 786-797. https://doi.org/10.1016/S0140-6736(23)01406-X
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., Costafreda, S. G., Dias, A., Fox, N., Gitlin, L. N., Howard, R., Kales, H. C., Kivimäki, M., Larson, E. B., Ogunniyi, A., . . . Mukadam, N. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396(10248), 413-446. https://doi.org/10.1016/S0140-6736(20)30367-6
How this NRP 513 Week 4 example is structured
The NRP/513 Week 4 work usually asks students to compare research designs and the questions each can answer. This paper uses real studies on one question, so the differences between designs appear in their actual findings rather than in abstract definitions. Students search this week as NRP 513 Week 4, NRP513 Wk 4 or NRP/513 Wk 4; all three are the same assignment.
NRP/513 Week 4 questions, answered
What does NRP/513 Week 4 usually ask for?
Many sections ask students to compare quantitative, qualitative and mixed methods designs and explain which questions each design can answer.
Why can't a cohort study prove cause?
Participants are not randomly assigned to exposures, so other differences between groups, known or unknown, may explain the association.
What if a randomized trial finds no overall effect?
The intervention may not work, the study may have been too short or underpowered, or effects may differ among subgroups. Prespecified subgroup findings can generate hypotheses but should be interpreted cautiously.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official University of Phoenix document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.